![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 04, 2022 12:34:47 PM
all it takes is a few bad actors to throw off the results .
The NIH has spent 10's of millions of dollars on the trial. They want it to succeed. None of the ACTIV trials have succeeded so they are desperate for a win. And it is a double blinded trial. It being sabotaged isn't realistic. We aren't in a Tom Cruise Mission Impossible movie. STAT's Matthew Herper sabotaged HGEN with his hit piece. Our share price has possibly been sabotaged by those who want to buy HGEN cheaply. The NIH isn't sabotaging us because they aren't sabotaging themselves.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM